MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s10147-026-03020-3

Медицинская библиотека · International journal of clinical oncology · 2026

Secondary primary tumors following iodine-125 low-dose-rate brachytherapy for localized prostate cancer.

Niwa Kojiro, Iinuma Koji, Nakano Masahiro, Tomioka Masayuki, Ito Masaya, Mori Takayuki, Kawase Kota, Taniguchi Tomoki, Tobisawa Yuki, Nakane Keita, Matsuo Masayuki, Koie Takuya

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Low-dose-rate brachytherapy with iodine-125 (LDR-BT) is an established curative radiation treatment modality for localized prostate cancer (PCa). This study aimed to evaluate the long-term incidence of secondary primary tumors (SPTs) following LDR-BT in Japanese patients with localized PCa and identify predictive factors associated with SPTs.

METHODS AND MATERIALS: We retrospectively reviewed the clinical records of 478 consecutive patients with localized PCa who underwent LDR-BT at the Gifu University Hospital. This study's primary endpoint was SPTs incidence, including bladder and rectal/anal cancers. The secondary endpoint was the identification of risk factors for LDR-BT that predicted SPTs development.

RESULTS

After a median follow-up period of 105 months, SPTs developed in 13 patients (2.7%). Bladder cancer and rectal/anal canal cancer were observed in seven (1.5%) and six (1.3%) patients, respectively. Multivariate analysis showed that a biologically effective dose (BED) ≥ 197 Gy was associated with increased risk of SPTs (hazard ratio 4.145; 95% confidence interval 1.108-15.498; p = 0.035).

CONCLUSIONS

The incidence of SPTs following LDR-BT was relatively low. In multivariate analysis, BED ≥ 197 Gy may be associated with an increased risk of SPT occurrence. Adequate tumor control can be achieved through appropriate radiation dose administration; carefully planned long-term follow-up may be beneficial for SPTs early detection.

Для цитирования: Niwa Kojiro, Iinuma Koji, Nakano Masahiro, Tomioka Masayuki, Ito Masaya, Mori Takayuki, Kawase Kota, Taniguchi Tomoki, Tobisawa Yuki, Nakane Keita, Matsuo Masayuki, Koie Takuya. Secondary primary tumors following iodine-125 low-dose-rate brachytherapy for localized prostate cancer.. International journal of clinical oncology. 2026. DOI: 10.1007/s10147-026-03020-3.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.